Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

132 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Innovations in ambulatory care].
Bodenmann P, Pasche O, Nanchen D, Jaunin-Stalder N, Marguerat I, Chapuis T, de Bosset V, Cornuz J. Bodenmann P, et al. Among authors: nanchen d. Rev Med Suisse. 2009 Jan 28;5(188):251-2, 254-7. Rev Med Suisse. 2009. PMID: 19267053 Review. French.
Evaluation of contemporary treatment of high- and very high-risk patients for the prevention of cardiovascular events in Europe - Methodology and rationale for the multinational observational SANTORINI study.
Ray KK, Haq I, Bilitou A, Aguiar C, Arca M, Connolly DL, Eriksson M, Ferrières J, Hildebrandt P, Laufs U, Mostaza JM, Nanchen D, Rietzschel E, Strandberg T, Toplak H, Visseren FLJ, Catapano AL. Ray KK, et al. Among authors: nanchen d. Atheroscler Plus. 2021 Aug 13;43:24-30. doi: 10.1016/j.athplu.2021.08.003. eCollection 2021 Sep. Atheroscler Plus. 2021. PMID: 36644508 Free PMC article.
Resting heart rate: what is normal?
Nanchen D. Nanchen D. Heart. 2018 Jul;104(13):1048-1049. doi: 10.1136/heartjnl-2017-312731. Epub 2018 Jan 30. Heart. 2018. PMID: 29382691 No abstract available.
Drinking patterns of alcohol and risk of major adverse cardiovascular events after an acute coronary syndrome.
Tessitore E, Branca M, Heg D, Nanchen D, Auer R, Räber L, Klingenberg R, Windecker S, Lüscher TF, Carballo S, Matter CM, Gmel G, Mukamal KJ, Rodondi N, Carballo D, Mach F, Gencer B. Tessitore E, et al. Among authors: nanchen d. Eur J Prev Cardiol. 2024 May 11;31(7):845-855. doi: 10.1093/eurjpc/zwad364. Eur J Prev Cardiol. 2024. PMID: 37995305
Initial systolic blood pressure associates with systemic inflammation, myocardial injury, and outcomes in patients with acute coronary syndromes.
Winzap PA, Kraler S, Obeid S, Wenzl FA, Templin C, Klingenberg R, von Eckardstein A, Roffi M, Muller O, Räber L, Lüscher TF; SPUM-ACS investigators. Winzap PA, et al. Eur Heart J Acute Cardiovasc Care. 2023 Jul 7;12(7):437-450. doi: 10.1093/ehjacc/zuad047. Eur Heart J Acute Cardiovasc Care. 2023. PMID: 37155643
Clinical outcomes in ST-segment elevation myocardial infarction patients undergoing percutaneous coronary interventions later than 48 h after symptom onset.
Rohla M, Temperli F, Siontis GCM, Klingenberg R, Gencer B, Rodondi N, Bär S, Nanchen D, Mach F, Häner JD, Pilgrim T, Muller O, Matter CM, Lüscher T, Roffi M, Heg D, Windecker S, Räber L. Rohla M, et al. Among authors: nanchen d. Eur Heart J Acute Cardiovasc Care. 2023 Jun 2;12(6):376-385. doi: 10.1093/ehjacc/zuad033. Eur Heart J Acute Cardiovasc Care. 2023. PMID: 36996409 Free article.
History of peripheral artery disease and cardiovascular risk of real-world patients with acute coronary syndrome: Role of inflammation and comorbidities.
Denegri A, Magnani G, Kraler S, Bruno F, Klingenberg R, Mach F, Gencer B, Räber L, Rodondi N, Rossi VA, Matter CM, Nanchen D, Obeid S, Lüscher TF. Denegri A, et al. Among authors: nanchen d. Int J Cardiol. 2023 Jul 1;382:76-82. doi: 10.1016/j.ijcard.2023.03.043. Epub 2023 Mar 21. Int J Cardiol. 2023. PMID: 36958395 Free article.
Low-density lipoprotein electronegativity and risk of death after acute coronary syndromes: A case-cohort analysis.
Kraler S, Wenzl FA, Vykoukal J, Fahrmann JF, Shen MY, Chen DY, Chang KC, Chang CK, von Eckardstein A, Räber L, Mach F, Nanchen D, Matter CM, Liberale L, Camici GG, Akhmedov A, Chen CH, Lüscher TF; SPUM-ACS investigators. Kraler S, et al. Among authors: nanchen d. Atherosclerosis. 2023 Jul;376:43-52. doi: 10.1016/j.atherosclerosis.2023.05.014. Epub 2023 May 24. Atherosclerosis. 2023. PMID: 37285778 Free article.
Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients.
Ridker PM, Revkin J, Amarenco P, Brunell R, Curto M, Civeira F, Flather M, Glynn RJ, Gregoire J, Jukema JW, Karpov Y, Kastelein JJP, Koenig W, Lorenzatti A, Manga P, Masiukiewicz U, Miller M, Mosterd A, Murin J, Nicolau JC, Nissen S, Ponikowski P, Santos RD, Schwartz PF, Soran H, White H, Wright RS, Vrablik M, Yunis C, Shear CL, Tardif JC; SPIRE Cardiovascular Outcome Investigators. Ridker PM, et al. N Engl J Med. 2017 Apr 20;376(16):1527-1539. doi: 10.1056/NEJMoa1701488. Epub 2017 Mar 17. N Engl J Med. 2017. PMID: 28304242 Free article. Clinical Trial.
132 results